Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III

Summary

This is a phase 2, randomized study where the aim of the study is to investigate the tolerance of adjuvant chemotherapy, measured by functional decline, after surgery for colon cancer stage III in elderly patients. Secondary aims are disease-free survival, toxicity, late functional outcome, quality of life, to establish a geriatric assessment for selection of patients, and to examine the prognostic value of gene signature tests / biomarkers for stage III colon cancer.

Timeline

Start

2016-06

Primary completion

2022-11

Completion

2025-01

Drugs

Indications